 |
|
|
Leading analyst and top management from fourteen sector firms examine the outlook for Brain & Spine Companies in this special 57-page issue from The Wall Street Transcript. |
 |
 |
 |
 |
 |
|
Click at the image to access the First Union Securities' Conference and to listen to the Live Audio of the presentations by the companies. |
|
 |
 |
 |
 |
Online subscribers to the Healthcare sector also get
JP Morgan H&Q 19th Healthcare Conference & Biotechnology Industry
- Emerging Trends in Treating the Brain & the Spine - In an in-depth (4,100 words) Analyst Interview, Andrew Jay, Analyst at First Union Securities, Inc., examines the outlook for the sector, discussing the prospects of several private companies, which may soon become IPOs if they are not acquired by larger public companies, and shares specific stock recommendations.
- CEO interviews (average 2,500 words). Top management of fourteen sector firms examine the outlook for their firm and the sector. Firms include:
Aspect Medical Systems, Accredo Health, Advanced Bionics, Avanir Pharmaceuticals, Cogent Neuroscience, Cortek, Corvas International, Micro Therapeutics, Neotonus, Neurogen, Orquest, Orthofix International N.V., Raymedica, Titan Pharmaceuticals.
This Issue costs $175 - and is non-returnable.
The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |